Atlas Trials

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

Clinical trial NCT01821625 · TERMINATED

Trial details

NCT number
NCT01821625
Sponsor
University of Texas Southwestern Medical Center
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
ThrombocytopeniaHepatitis C
Start date
2013-04-01
Primary completion
2015-04-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.